Phosphocalcic metabolism after biliopancreatic diversion

Obesity Surgery

Volumn 17, Issue 5, 2007, Pages 642-648

  Lozano, O ^a   Garcia Diaz J D ^a   Cancer, E ^a   Arribas, I ^a   Rubio, J L ^a   Gonzalez Garcia I ^a   Galvan M ^a   Alvarez J ^a   Martin Duce A ^a,b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b NONE   (Spain)

Author keywords

Biliopancreatic diversion; Morbid obesity; Obesity surgery; Parathyroid hormone; Pyridinolines; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; PYRROLIDINE DERIVATIVE;

ABSORPTION; ADULT; ARTICLE; BILIOPANCREATIC BYPASS; BODY MASS; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CALCIUM URINE LEVEL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; MORBID OBESITY; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM;

EID: 34250647022     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-007-9108-0     Document Type: Article

References (48)

1. Hey H, Stokholm KH, Lund B et al. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Int J Obes 1982; 6: 473-9.
2. Liel Y, Ulmer E, Shary J et al. Low circulating vitamin D in obesity. Calcif Tissue Int 1988; 43: 199-201.
3. Hyldstrup L, Andersen T, McNair P et al. Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction. Acta Endocrinol (Copenh) 1993; 129: 393-8.
4. Higgins M, Kannel W, Garrison R et al. Hazards of obesity: The Framinghan experience. Acta Med Scand 1987; 72 (Suppl): 23-36.
5. Manolio TA, Savage PJ, Burke GL et al. Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study. Arteriosclerosis 1990; 10: 430-6.
6. Compston JE, Vedi S, Ledger JE et al. Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr 1981; 34: 2359-63.
7. Bell NH, Epstein S, Greene A et al. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985; 76: 370-3.
8. Wortsman J, Matsuoka LY, Chen TC et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-3.
9. Aranceta J, Serra-Majem L, Perez-Rodrigo C et al. Vitamins in Spanish food patterns: the eVe Study. Public Health Nutr 2001; 4 (6A): 1317-23.
10. Payne JH, DeWind LT, Commons RR. Metabolics observations in patients with jejunocolic shunts. Am J Surg 1963; 106: 273-7.
11. Griffen WO Jr, Bivins BA, Bell RM. The decline and fall of the jejunoileal bypass. Surg Gynecol Obstet 1983; 157: 301-8.
12. Deitel M, Shahi B, Anand PK. Long-term outcome in a series of jejunoileal bypass patients. Obes Surg 1993; 3: 247-52.
13. Scopinaro N, Gianetta E, Civalleri D et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg 1979; 66: 618-20.
14. Compston JE, Vedi S, Gianetta E et al. Bone histomorphometry and vitamin D status after biliopancreatic bypass for obesity. Gastroenterology 1984; 87: 350-6.
15. Holian D, Clare M. Biliopancreatic bypass for morbid obesity: late results and complications. Clin Nutr 1986; 5: 133-6.
16. Chapin BL, LeMar HJ Jr, Knodel DH et al. Secondary hyperparathyroidism following biliopancreatic diversion. Arch Surg 1996; 131: 1048-52.
17. Larrad A, de la Fuente F, Sánchez Cabezudo C et al. Pre- and postoperative modifications of plasma parathyroid hormone concentrations in biliopancreatic diversion of Larrad. Cir Esp 2002; 72: 186-91.
18. Hamoui N, Kim K, Anthone G et al. The significance of elevated levels of parathyroid hormone in patients with morbid obesity before an after bariatric surgery. Arch Surg 2003; 138: 891-7.
19. Larrad A, Moreno B, Sánchez Cabezudo C et al. Comparative study between vertical banded gastroplasty and biliopancreatic bypass for the treatment of morbid obesity. Cir Esp 1999; 66: 297-302.
20. Greenstein RJ, Belachew M. Implantable gastric stimulation (IGS) as therapy for human morbid obesity: report from the 2001 IFSO symposium in Crete. Obes Surg 2002; 12 (Suppl 1): 3S-5S.
21. Atkinson RL, Dahms WT, Bray GA et al. Parathyroid hormone levels in obesity: effects of intestinal bypass surgery. Miner Electrolyte Metab 1978; 1: 315-20.
22. Hamoui N, Anthone G, Crookes PF. Calcium metabolism in the morbidly obese. Obes Surg 2004; 14: 9-12.
23. Buffington C, Walker B, Cowan GS et al. Vitamin D deficiency in the morbidly obese. Obes Surg 1993; 3: 421-4.
24. Larrad-Jimenez A, Sánchez Cabezudo C, De Quadros Borrajo PP et al. Course of metabolic syndrome following the biliopancreatic diversion of Larrad. Obes Surg 2004; 14; 1176-81.
25. Seibel MJ, Gartenberg F, Silverberg SJ et al. Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism. J Clin Endocrinol Metab 1992; 74: 481-6.
26. Sorensen HA, Frendsen NJ, Hyldstrup L. Late calcium metabolic consequences of jejunoileal bypass. Obes Surg 1992; 2: 219-23.
27. Bano G, Rodin DA, Pazianas M et al. Reduced bone mineral density after surgical treatment for obesity. Int J Obes 1999; 23: 361-5.
28. Pilkington TR, Gazet JC, Compston JE et al. Musculo-skeletal abnormalities after jejunoileal bypass. Int J Obes 1981; 5: 509-12.
29. Scopinaro N, Adami GF, Marinari GM et al. Biliopancreatic diversion. World J Surg 1998; 22: 936-46.
30. Marceau P, Hould FS, Simard S et al. Biliopancreatic diversion with duodenal switch. World J Surg 1998; 22: 947-54.
31. Morgan DB, Paterson CR, Woods CG et al. Osteomalacia after gastrectomy: a response to very small dosis of vitamin D. Lancet 1965; 2: 1089-91.
32. Eddy RL. Metabolic bone disease after gastrectomy. Am J Med 1971; 50: 442-9.
33. Newbury L, Dolan K, Hatifotis M et al. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg 2003; 13: 893-5.
34. Mellstrom D, Johansson C, Johnell O et al. Osteoporosis, metabolic aberrations, and increased risk for vertebral fractures after partial gastrectomy. Calcif Tissue Int 1993; 53: 370-7.
35. Nilas L, Christiansen C. Influence of PTH and 1,25 (OH)2D on calcium homeostasis and bone mineral content after gastric surgery. Calcif Tissue Int 1985; 37: 461-6.
36. Klein KB, Orwoll ES, Lieberman DA et al. Metabolic bone disease in asymptomatic men after partial gastrectomy with Billroth II anastomosis. Gastroenterology 1987; 92: 608-16.
37. Rao DS, Kleerekoper M, Rogers M et al. Is gastrectomy a risk factor for osteoporosis? In: Christiansen C, Armand CD, Nordin BEC et al, eds. Osteoporosis. Proc of the Copenhagan International Symposium on Osteoporosis. Aalborg Stiftsbogtrykkeri, Copenhagan: 1984: 775-81.
38. Riggs BL, O'Fallon WM, Muhs J et al. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res 1998; 13: 168-74.
39. Fardellone P, Brazier M, Kamel S et al. Biochemical effects of calcium supplementation in postmenopausal women: influence of dietary calcium intake. Am J Clin Nutr 1998; 67: 1273-8.
40. Ricci TA, Chowdhury HA, Heymsfield SB et al. Calcium supplementation suppresses bone turnover during weight reduction in postmenopausal women. J Bone Miner Res 1998; 13: 1045-50.
41. Jensen LB, Kollerup G, Quaade F et al. Bone mineral changes in obese women during a moderate weight loss with and without calcium supplementation. J Bone Miner Res 2001; 16: 141-7.
42. Horowitz M, Wishart JM, Goh D et al. Oral calcium suppresses biochemical markers of bone resorption in normal men. Am J Clin Nutr 1994; 60: 965-8.
43. Sairanen S, Karkkainen M, Tahtela R et al. Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25- dihydroxyvitamin D (Calcitriol) for four years. Calcif Tissue Int 2000; 67: 122-7.
44. Peacock M, Liu G, Carey M et al. Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab 2000; 85: 3011-9.
45. Scopinaro N, Gianetta E, Adami GF et al. Biliopancreatic diversion for obesity at eighteen years. Surgery 1996; 119: 261-68.
46. Moreiro J, Ruiz O, Perez G et al. Parathyroid hormone and bone marker levels in patients with morbid obesity before and after biliopancreatic diversion. Obes Surg 2007; 17: 348-54.
47. Larrad-Jiménez A, Sánchez-Cabezudo Diaz-Guerra C, de Caudros Borrajo P et al. Short-, mid- and longterm results of Larrad biliopancreatic diversion. Obes Surg 2007; 17: 202-10.
48. Dawson-Hughes B, Harris SS, Krall EA et al. Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women. Am J Clin Nutr 2000; 72: 745-50.